Delivery Order SPE2DB22D3301-SPE2DB25FZ1DA
Award Date 9/17/25
Potential Completion Date 10/8/25
Potential Value $116K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,981.60 to AmerisourceBergen Drug Corp for GAMUNEX-C, a 40-gram/400 milliliter immunoglobulin vial. The contract, issued on August 6, 2025, carries a firm fixed price and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials with a completion date of September 23, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is structured as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $55,852.80 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of October 9, 2025, and was awarded on September 18, 2025. This award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. The performance location...
- The Defense Logistics Agency awarded a delivery order valued at $34,908.00 to AmerisourceBergen Drug Corp for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract was competitively awarded on August 20, 2025, with a firm fixed price structure and an ultimate completion date of September 11, 2025. This non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $23,602.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 4, 2025, with completion targeted for September 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $6,981.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of GAMUNEX-C 40 Gram/400 ML Vial (400ML). The contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order carries an ultimate completion date of October 6, 2025, and was awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of GAMUNEX-C 5 gram/50 milliliter vials valued at $3,036.70. This non-set-aside, firm fixed-price delivery order will be completed by October 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GAMUNEX-C 20 gram/200 milliliter vials valued at $11,651.54 under a firm fixed-price contract with an ultimate completion date of August 18, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,937.12 to AmerisourceBergen Drug Corp for GAMUNEX-C 1 gram/10 milliliter vials on August 19, 2025, with completion targeted for September 10, 2025. This firm fixed price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of GAMUNEX-C 40 Gram/400 mL vials valued at $4,654.40 with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...